Home › Funds › RTW INVESTMENTS, LP › CYTK
RTW INVESTMENTS, LP position in CYTK
CYTOKINETICS INC · Health Care
RTW INVESTMENTS, LP reported holding 2,862,003 shares of CYTK (CYTOKINETICS INC) in its Q3 2026 13F filing — a position valued at US$188.6M, representing 1.90% of its reported portfolio and ranking #17 among its reported holdings. RTW INVESTMENTS, LP has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How RTW INVESTMENTS, LP's CYTK position evolved
RTW INVESTMENTS, LP first disclosed a stake in CYTK in Q3 2023 at 2,574,198 shares (US$75.8M). The position peaked in Q2 2026 at 2,862,003 shares, worth US$243.8M. Across 13 filings, RTW INVESTMENTS, LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 9 time(s). The most recent filing (Q3 2026) shows 2,862,003 shares valued at US$188.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.57M | $75.84M | New |
| Q4 2023 | 2.53M | $210.82M | Reduce |
| Q1 2024 | 2.53M | $177.03M | Hold |
| Q2 2024 | 2.72M | $147.43M | Add |
| Q3 2024 | 2.72M | $143.68M | Hold |
| Q4 2024 | 2.72M | $128.00M | Hold |
| Q1 2025 | 2.72M | $109.36M | Hold |
| Q2 2025 | 2.72M | $89.91M | Hold |
| Q3 2025 | 2.72M | $149.55M | Hold |
| Q4 2025 | 2.72M | $172.90M | Hold |
| Q1 2026 | 2.72M | $179.35M | Hold |
| Q2 2026 | 2.86M | $243.81M | Add |
| Q3 2026 | 2.86M | $188.63M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CYTK and 13F data
CYTK (CYTOKINETICS INC) is a Health Care company. 39 other funds we track also report a position in CYTK — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.59B), Avoro Capital Advisors LLC (US$323.0M), Polar Capital Holdings Plc (US$227.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CYTK
- T. Rowe Price Investment Management, Inc. 18.72M sh · $1.59B · Q2 2026
- Avoro Capital Advisors LLC 4.90M sh · $322.96M · Q3 2026
- Polar Capital Holdings Plc 9.64M sh · $227.69M · Q3 2026
- Frazier Life Sciences Management, L.P. 1.16M sh · $98.81M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.18M sh · $77.79M · Q3 2026
- Integral Health Asset Management, LLC 1.60M sh · $72.50M · Q3 2026
- GW&K Investment Management, LLC 1.02M sh · $67.08M · Q3 2026
- Royalty Pharma Sub-Manager, LLC 980.39K sh · $64.62M · Q3 2026
- Foresite Capital Management IV, LLC 714.70K sh · $60.88M · Q2 2026
- Melqart Asset Management (UK) Ltd 761.54K sh · $50.19M · Q3 2026
- Affinity Asset Advisors, LLC 750.00K sh · $49.43M · Q3 2026
More on RTW INVESTMENTS, LP
FAQ
How long has RTW INVESTMENTS, LP held CYTK?
RTW INVESTMENTS, LP has disclosed CYTK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is RTW INVESTMENTS, LP's current position in CYTK?
As of Q3 2026, RTW INVESTMENTS, LP holds 2.86M shares of CYTK (CYTOKINETICS INC), valued at $188.63M, representing 1.90% of its reported portfolio and ranking #17.
Has RTW INVESTMENTS, LP been buying or selling CYTK?
In the latest 13F filing (Q3 2026), RTW INVESTMENTS, LP held unchanged its position in CYTK. The position peaked in Q2 2026 at 2.86M shares.
Which other funds hold CYTK?
Other major institutional holders of CYTK include T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, Polar Capital Holdings Plc, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.